Text Size
5 studies found for:    17167137 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Withdrawn A Study of Bevacizumab to Prevent Malignant Ascites
Condition: Malignant Ascites
Intervention: Drug: Bevacizumab
2 Completed A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-small Cell Lung Cancer
Condition: Tumors
Interventions: Drug: CA4P;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: Paclitaxel
3 Active, not recruiting Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy
Condition: Lung Cancer
Intervention: Drug: Bortezomib
4 Recruiting Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy
Condition: Squamous Cell Lung Cancer
Interventions: Drug: Boanmycin;   Drug: Docetaxel
5 Completed Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Biological: bevacizumab;   Other: laboratory biomarker analysis
To Top

† Indicates status has not been verified in more than two years